Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2017 |
| Author/s |
author: Paolo Giovanni Casali Ezia Bello Maurizio D'Incalci Paola Collini Angelo Paolo Dei Tos Salvatore L. Renne Roberta Frapolli Denis Cominetti Silvia Stacchiotti Valentina Zuco Alessandro Gronchi Carlo Morosi Nadia Zaffaroni |
| Publication date | March 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |